MoonLake Immunotherapeutics (MLTX) Sector
Health Care

(Current) $44.21
0.85 (1.96%) Open Price: 44.21

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients

(06/13/25) $44.21
(06/15/25) $43.36
(06/15/25) (Qty.)316,293
(06/13/25) $42.97
(06/13/25) $44.43
(05/25/25) $37.79
(06/01/25) $52.88
Stocktwits
LetsEncrypt SSL Secure Stripe Payment Processing